Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Alberto Cruz-Bermúdez"'
Autor:
Amelia Insa, Mariano Provencio, Bartomeu Massutí, Margarita Majem, Delvys Rodriguez-Abreu, Manuel Cobo, Manuel Dómine, Ernest Nadal, Belén Sierra-Rodero, Alberto Cruz-Bermúdez, Alex Martinez-Marti, Javier De Castro Carpeño, Guillermo López Vivanco, Edel Del Barco, Nuria Viñolas, Isidoro Barneto Aranda, Marta Casarrubios, Atocha Romero, Reyes Bernabe, María del Rosario García-Campelo, Martín Lázaro-Quintela, Cristina Martinez-Toledo, Ismael Fernández-Miranda, Roberto Serna-Blanco, Virginia Calvo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Neoadjuvant chemoimmunotherapy for non-small cell lung cancer (NSCLC) has improved pathological responses and survival rates compared with chemotherapy alone, leading to Food and Drug Administration (FDA) approval of nivolumab plus chemoth
Externí odkaz:
https://doaj.org/article/536d1ef3434247f3bec7c014036712de
Autor:
Amelia Insa, Mariano Provencio, Bartomeu Massutí, Margarita Majem, Delvys Rodriguez-Abreu, Manuel Cobo, Manuel Dómine, Joaquín Casal-Rubio, Ernest Nadal, Belén Sierra-Rodero, Alberto Cruz-Bermúdez, Yago Garitaonaindía, Joaquín Mosquera, Alex Martinez-Marti, Javier De Castro Carpeño, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Raquel Laza-Briviesca, Marta Casarrubios, Aránzazu García-Grande, Atocha Romero, Fernando Franco
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/ec8ebeacfddb4e4b8303a2a08265fda0
Autor:
Roberto Serna-Blasco, Estela Sánchez-Herrero, Lucía Robado de Lope, Sandra Sanz-Moreno, Alejandro Rodríguez-Festa, Dunixe Ares-Trotta, Alberto Cruz-Bermúdez, Fabio Franco, Alfredo Sánchez-Hernández, María de Julián Campayo, Carlos García-Girón, Manuel Dómine, Ana Blasco, José M. Sánchez, Juana Oramas, Joaquim Bosch-Barrera, María Á. Sala, María Sereno, Atocha Romero, Mariano Provencio
Publikováno v:
Cancers, Vol 14, Iss 18, p 4446 (2022)
Tumor molecular profiling upon disease progression enables investigations of the tumor evolution. Next-generation sequencing (NGS) of liquid biopsies constitutes a noninvasive readily available source of tumor molecular information. In this study, 12
Externí odkaz:
https://doaj.org/article/fbefb4723b93488996868c6f1d0d8a8d
Autor:
Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García‐Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta Casarrubios, Belén Sierra‐Rodero, Carlos Tarín, Aránzazu García‐Grande, Cara Haymaker, Ignacio I. Wistuba, Atocha Romero, Fernando Franco, Mariano Provencio
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 7, Pp n/a-n/a (2021)
Abstract Background Immunotherapy is being tested in early‐stage non‐small cell lung cancer (NSCLC), and achieving higher rates of complete pathological responses (CPR) as compared to standard of care. Early identification of CPR patients has vit
Externí odkaz:
https://doaj.org/article/0ad46e49a0734ef1b5f505f363328cb9
Autor:
Alberto Cruz-Bermúdez, Raquel Laza-Briviesca, Marta Casarrubios, Belén Sierra-Rodero, Mariano Provencio
Publikováno v:
Biomedicines, Vol 9, Iss 4, p 361 (2021)
The tumor microenvironment exhibits altered metabolic properties as a consequence of the needs of tumor cells, the natural selection of the most adapted clones, and the selfish relationship with other cell types. Beyond its role in supporting uncontr
Externí odkaz:
https://doaj.org/article/492318e13a4d48c18a49c8eb7b2091b4
Autor:
Alberto Cruz-Bermúdez, Ramiro J Vicente-Blanco, Rosana Hernández-Sierra, Mayte Montero, Javier Alvarez, Mar González Manrique, Alberto Blázquez, Miguel Angel Martín, Carmen Ayuso, Rafael Garesse, Miguel A Fernández-Moreno
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146816 (2016)
The presence of more than one non-severe pathogenic mutation in the same mitochondrial DNA (mtDNA) molecule is very rare. Moreover, it is unclear whether their co-occurrence results in an additive impact on mitochondrial function relative to single m
Externí odkaz:
https://doaj.org/article/82f5fcaa9c1f4e038f4b5ba1a6d3376d
Autor:
Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal, Amelia Insa, M. Rosario García-Campelo, Joaquín Casal Rubio, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Eva Pereira, Ana Royuela, Virginia Calvo, Javier Martín-López, Francisco García-García, Marta Casarrubios, Fernando Franco, Estela Sánchez-Herrero, Bartomeu Massuti, Alberto Cruz-Bermúdez, Atocha Romero
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
PURPOSE Neoadjuvant chemotherapy plus nivolumab has been shown to be effective in resectable non–small-cell lung cancer (NSCLC) in the NADIM trial (ClinicalTrials.gov identifier: NCT03081689 ). The 3-year overall survival (OS) and circulating tumor
Publikováno v:
American Society of Clinical Oncology Educational Book. :711-728
The treatment scenario for patients with resectable non–small cell lung cancer has changed dramatically with the incorporation of immunotherapy. The introduction of immunotherapy into treatment algorithms has yielded improved clinical outcomes in s
Autor:
Humam Kadara, Ignacio I. Wistuba, Mariano Provencio, Luisa M. Solis, Tina Cascone, Boris Sepesi, J. Jack Lee, Don L. Gibbons, John V. Heymach, Stephen G. Swisher, Junya Fujimoto, Cara Haymaker, Edwin R. Parra, Apar Pataer, Ximing Tang, Wei Lu, Carmen Behrens, Katsuhiro Yoshimura, Beatriz Sanchez-Espiridon, Neus Bota-Rabassedas, Alberto Cruz-Bermúdez, Raquel Laza-Briviesca, Jiexin Zhang, Pedro Rocha
Supplementary Figure from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::177ba53f3455b987fe3027411654bdcc
https://doi.org/10.1158/1078-0432.22486917
https://doi.org/10.1158/1078-0432.22486917
Autor:
Humam Kadara, Ignacio I. Wistuba, Mariano Provencio, Luisa M. Solis, Tina Cascone, Boris Sepesi, J. Jack Lee, Don L. Gibbons, John V. Heymach, Stephen G. Swisher, Junya Fujimoto, Cara Haymaker, Edwin R. Parra, Apar Pataer, Ximing Tang, Wei Lu, Carmen Behrens, Katsuhiro Yoshimura, Beatriz Sanchez-Espiridon, Neus Bota-Rabassedas, Alberto Cruz-Bermúdez, Raquel Laza-Briviesca, Jiexin Zhang, Pedro Rocha
Purpose:Our understanding of the immunopathology of resectable non–small cell lung cancer (NSCLC) is still limited. Here, we explore immune programs that inform of tumor immunity and response to neoadjuvant chemotherapy and chemoimmunotherapy in lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758466c45170c4b13db8daef12f552c4
https://doi.org/10.1158/1078-0432.c.6532419.v1
https://doi.org/10.1158/1078-0432.c.6532419.v1